Immunovant, Inc.IMVTNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, above historical average, structural decline.
Left:
||||
Free cash flow yield
Latest
-14.54%
↑ 45% above average
Average (7y)
-26.22%
Historical baseline
Range
High:-4.92%
Low:-128.95%
CAGR
-26.8%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2025 | -14.54% | -195.8% |
| 2024 | -4.92% | +50.2% |
| 2023 | -9.87% | +43.9% |
| 2022 | -17.60% | -196.6% |
| 2021 | -5.93% | +25.2% |
| 2020 | -7.94% | +60.3% |
| 2019 | -19.99% | +84.5% |
| 2018 | -128.95% | - |